IL-36 expression plays a potential role in acute kidney injury through down-regulation of inflammatory response

2016 ◽  
Vol 5 (1) ◽  
pp. 16-26 ◽  
Author(s):  
Heather Hatcher ◽  
◽  
Yukio Tsung ◽  
Shao-Ling Qin ◽  
Chris Clarkson ◽  
...  
2020 ◽  
Vol 40 (6) ◽  
Author(s):  
Xudong Wang ◽  
Yali Wang ◽  
Mingjian Kong ◽  
Jianping Yang

Abstract Background: Septic acute kidney injury is considered as a severe and frequent complication that occurs during sepsis. The present study was performed to understand the role of miR-22-3p and its underlying mechanism in sepsis-induced acute kidney injury. Methods: Rats were injected with adenovirus carrying miR-22-3p or miR-NC in the caudal vein before cecal ligation. Meanwhile, HK-2 cells were transfected with the above adenovirus following LPS stimulation. We measured the markers of renal injury (blood urea nitrogen (BUN), serum creatinine (SCR)). Histological changes in kidney tissues were examined by hematoxylin and eosin (H&E), Masson staining, periodic acid Schiff staining and TUNEL staining. The levels of IL-1β, IL-6, TNF-α and NO were determined by ELISA assay. Using TargetScan prediction and luciferase reporter assay, we predicted and validated the association between PTEN and miR-22-3p. Results: Our data showed that miR-22-3p was significantly down-regulated in a rat model of sepsis-induced acute kidney injury, in vivo and LPS-induced sepsis model in HK-2 cells, in vitro. Overexpression of miR-22-3p remarkably suppressed the inflammatory response and apoptosis via down-regulating HMGB1, p-p65, TLR4 and pro-inflammatory factors (IL-1β, IL-6, TNF-α and NO), both in vivo and in vitro. Moreover, PTEN was identified as a target of miR-22-3p. Furthermore, PTEN knockdown augmented, while overexpression reversed the suppressive role of miR-22-3p in LPS-induced inflammatory response. Conclusions: Our results showed that miR-22-3p induced protective role in sepsis-induced acute kidney injury may rely on the repression of PTEN.


2012 ◽  
Vol 38 (3) ◽  
pp. 467-473 ◽  
Author(s):  
Perrine Hoet ◽  
Vincent Haufroid ◽  
Gladys Deumer ◽  
Xavier Dumont ◽  
Dominique Lison ◽  
...  

2018 ◽  
Vol 50 (11) ◽  
pp. 2099-2107 ◽  
Author(s):  
Jinlong Teng ◽  
Mingjun Liu ◽  
Yuan Su ◽  
Kun Li ◽  
Na Sui ◽  
...  

Nutrients ◽  
2016 ◽  
Vol 8 (3) ◽  
pp. 165 ◽  
Author(s):  
Juey-Ming Shih ◽  
Yao-Ming Shih ◽  
Man-Hui Pai ◽  
Yu-Chen Hou ◽  
Chiu-Li Yeh ◽  
...  

2013 ◽  
Vol 83 (6) ◽  
pp. 1087-1098 ◽  
Author(s):  
Punithavathi V. Ranganathan ◽  
Calpurnia Jayakumar ◽  
Riyaz Mohamed ◽  
Zheng Dong ◽  
Ganesan Ramesh

2021 ◽  
Vol 9 ◽  
Author(s):  
James D. Odum ◽  
Hector R. Wong ◽  
Natalja L. Stanski

Sepsis is a leading cause of morbidity and mortality in critically ill children, and acute kidney injury (AKI) is a frequent complication that confers an increased risk for poor outcomes. Despite the documented consequences of sepsis-associated AKI (SA-AKI), no effective disease-modifying therapies have been identified to date. As such, the only treatment options for these patients remain prevention and supportive care, both of which rely on the ability to promptly and accurately identify at risk and affected individuals. To achieve these goals, a variety of biomarkers have been investigated to help augment our currently limited predictive and diagnostic strategies for SA-AKI, however, these have had variable success in pediatric sepsis. In this mini-review, we will briefly outline the current use of biomarkers for SA-AKI, and propose a new framework for biomarker discovery and utilization that considers the individual patient's sepsis inflammatory response. Now recognized to be a key driver in the complex pathophysiology of SA-AKI, understanding the dysregulated host immune response to sepsis is a growing area of research that can and should be leveraged to improve the prediction and diagnosis of SA-AKI, while also potentially identifying novel therapeutic targets. Reframing SA-AKI in this manner – as a direct consequence of the individual patient's sepsis inflammatory response – will facilitate a precision medicine approach to its management, something that is required to move the care of this consequential disorder forward.


Sign in / Sign up

Export Citation Format

Share Document